Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 4/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.51 |
| ▸ | POLB | P06746 | 2/20 | 0.51 |
| ▸ | GABBR2 | O75899 | 5/20 | 0.50 |
| ▸ | GABBR1 | Q9UBS5 | 5/20 | 0.50 |
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.50 |
| ▸ | THRB | P10828 | 2/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.50 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.50 |
| ▸ | DRD3 | P35462 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.42 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL22831450 | 0.98 | CYP2C9 (0.50) | CYP2C9KMT2ACYP2C19MEN1CYP2D6 | |
| SCHEMBL27400979 | 0.89 | POLB (0.49) | CYP2C9KMT2ACYP2C19MEN1CYP2D6 | |
| SCHEMBL4826506 | 0.85 | GABBR2 (0.46) | CYP2C9KMT2ACYP2C19MEN1CYP2D6 | |
| SCHEMBL5860866 | 0.85 | GABBR2 (0.58) | CYP2C9KMT2ACYP2C19MEN1CYP2D6 | |
| SCHEMBL31344403 | 0.85 | GABBR2 (0.58) | CYP2C9KMT2ACYP2C19MEN1CYP2D6 | |
| Hydrochloric Acid SCHEMBL191270 | 0.83 | GABBR2 (0.56) | CYP2C9KMT2ACYP2C19MEN1CYP2D6 | |
| SCHEMBL22397201 | 0.83 | POLB (0.53) | CYP2C9KMT2ACYP2C19MEN1CYP2D6 | |
| Hydrochloric Acid SCHEMBL191271 | 0.83 | GABBR2 (0.56) | CYP2C9KMT2ACYP2C19MEN1CYP2D6 | |
| SCHEMBL1613696 | 0.82 | HRH1 (0.56) | CYP2C19CYP2D6POLBGABBR2GABBR1 | |
| SCHEMBL6344322 | 0.81 | POLB (0.55) | CYP2C9KMT2ACYP2C19MEN1CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0103261-B1 | Continuous extraction of polyphenylene sulfide | PHILLIPS PETROLEUM CO (US) | 1995-07-19 | — | — | EP | claimed |
| EP-0103261-A2 | Continuous extraction of polyphenylene sulfide | PHILLIPS PETROLEUM COMPANY (US) | 1984-03-21 | — | — | EP | claimed |
| US-20230340026-A1 | COMPOUNDS | NEW PHARMA LICENCE HOLDINGS LTD (MT) | 2023-10-26 | — | — | US | disclosed |
| US-20180030092-A1 | COMPOUNDS | SPERO THERAPEUTICS, INC. | 2018-02-01 | — | — | US | disclosed |
| EP-3224273-A1 | COMPOUNDS | New Pharma Licence Holdings Limited (MT) | 2017-10-04 | — | — | EP | disclosed |
| WO-2016083531-A1 | COMPOUNDS | NEW PHARMA LICENCE HOLDINGS LIMITED (MT) | 2016-06-02 | — | — | WO | disclosed |
| CN-102060713-A | Aromatic amine hapten for detecting azo dyes and preparation method thereof | JIAXING ENTRY EXIT INSPECTION AND QUARANTINE BUREAU OF P R C | 2011-05-18 | — | — | CN | disclosed |
| US-7402652-B2 | Baclofen conjugate and a pharmaceutical composition for treatment of neuronal disorders | MILLER LANDON C G | 2008-07-22 | — | — | US | disclosed |
| US-20060058221-A1 | Baclofen conjugate and a pharmaceutical composition for treatment of neuronal disorders | MILLER LANDON C | 2006-03-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230340026-A1 | COMPOUNDS | BCAT1, BCAT2, CCNT1 | CYP2C9 980/4885KMT2A 3019/4885CYP2C19 1733/4885 |
| US-20180030092-A1 | COMPOUNDS | BCAT1, BCAT2, IL4I1 | CYP2C9 643/4885KMT2A 3824/4885CYP2C19 1307/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.